table of content
1 Study Coverage
1.1 Connected Injectable Drug Delivery Devices Product Introduction
1.2 Global Connected Injectable Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Connected Injectable Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.3 United States Connected Injectable Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Connected Injectable Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Connected Injectable Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.4 Connected Injectable Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Connected Injectable Drug Delivery Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Connected Injectable Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Connected Injectable Drug Delivery Devices Market Dynamics
1.5.1 Connected Injectable Drug Delivery Devices Industry Trends
1.5.2 Connected Injectable Drug Delivery Devices Market Drivers
1.5.3 Connected Injectable Drug Delivery Devices Market Challenges
1.5.4 Connected Injectable Drug Delivery Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Connected Injectable Drug Delivery Devices Market Segment by Type
2.1.1 Conventional Injection Devices
2.1.2 Self-Injection Devices
2.1.3 Others
2.2 Global Connected Injectable Drug Delivery Devices Market Size by Type
2.2.1 Global Connected Injectable Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Connected Injectable Drug Delivery Devices Market Size by Type
2.3.1 United States Connected Injectable Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Connected Injectable Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Connected Injectable Drug Delivery Devices Market Segment by Application
3.1.1 Diabetes
3.1.2 Cardiovascular Diseases
3.1.3 Autoimmune Diseases
3.1.4 Hormones Replacement
3.1.5 Neurology
3.1.6 Addiction
3.1.7 Respiratory Diseases
3.1.8 Others
3.2 Global Connected Injectable Drug Delivery Devices Market Size by Application
3.2.1 Global Connected Injectable Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Connected Injectable Drug Delivery Devices Market Size by Application
3.3.1 United States Connected Injectable Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Connected Injectable Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Connected Injectable Drug Delivery Devices Competitor Landscape by Company
4.1 Global Connected Injectable Drug Delivery Devices Market Size by Company
4.1.1 Top Global Connected Injectable Drug Delivery Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Connected Injectable Drug Delivery Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Connected Injectable Drug Delivery Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Connected Injectable Drug Delivery Devices Price by Manufacturer (2017-2022)
4.2 Global Connected Injectable Drug Delivery Devices Concentration Ratio (CR)
4.2.1 Connected Injectable Drug Delivery Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Connected Injectable Drug Delivery Devices in 2021
4.2.3 Global Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Connected Injectable Drug Delivery Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Connected Injectable Drug Delivery Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Connected Injectable Drug Delivery Devices Product Type
4.3.3 Date of International Manufacturers Enter into Connected Injectable Drug Delivery Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Connected Injectable Drug Delivery Devices Market Size by Company
4.5.1 Top Connected Injectable Drug Delivery Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Connected Injectable Drug Delivery Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Connected Injectable Drug Delivery Devices Sales by Players (2020, 2021 & 2022)
5 Global Connected Injectable Drug Delivery Devices Market Size by Region
5.1 Global Connected Injectable Drug Delivery Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Connected Injectable Drug Delivery Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Connected Injectable Drug Delivery Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Connected Injectable Drug Delivery Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Connected Injectable Drug Delivery Devices Sales in Value by Region: 2017-2022
5.3.2 Global Connected Injectable Drug Delivery Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.1.2 North America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Connected Injectable Drug Delivery Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Phillips-Medisize
7.1.1 Phillips-Medisize Corporation Information
7.1.2 Phillips-Medisize Description and Business Overview
7.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Phillips-Medisize Connected Injectable Drug Delivery Devices Products Offered
7.1.5 Phillips-Medisize Recent Development
7.2 West Pharmaceutical Services
7.2.1 West Pharmaceutical Services Corporation Information
7.2.2 West Pharmaceutical Services Description and Business Overview
7.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Products Offered
7.2.5 West Pharmaceutical Services Recent Development
7.3 Biocorp
7.3.1 Biocorp Corporation Information
7.3.2 Biocorp Description and Business Overview
7.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Biocorp Connected Injectable Drug Delivery Devices Products Offered
7.3.5 Biocorp Recent Development
7.4 Aterica
7.4.1 Aterica Corporation Information
7.4.2 Aterica Description and Business Overview
7.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Aterica Connected Injectable Drug Delivery Devices Products Offered
7.4.5 Aterica Recent Development
7.5 Unilife
7.5.1 Unilife Corporation Information
7.5.2 Unilife Description and Business Overview
7.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Unilife Connected Injectable Drug Delivery Devices Products Offered
7.5.5 Unilife Recent Development
7.6 Propeller Health
7.6.1 Propeller Health Corporation Information
7.6.2 Propeller Health Description and Business Overview
7.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Propeller Health Connected Injectable Drug Delivery Devices Products Offered
7.6.5 Propeller Health Recent Development
7.7 Haselmeier
7.7.1 Haselmeier Corporation Information
7.7.2 Haselmeier Description and Business Overview
7.7.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Haselmeier Connected Injectable Drug Delivery Devices Products Offered
7.7.5 Haselmeier Recent Development
7.8 SHL
7.8.1 SHL Corporation Information
7.8.2 SHL Description and Business Overview
7.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 SHL Connected Injectable Drug Delivery Devices Products Offered
7.8.5 SHL Recent Development
7.9 Becton Dickinson
7.9.1 Becton Dickinson Corporation Information
7.9.2 Becton Dickinson Description and Business Overview
7.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Becton Dickinson Connected Injectable Drug Delivery Devices Products Offered
7.9.5 Becton Dickinson Recent Development
7.10 Baxter International
7.10.1 Baxter International Corporation Information
7.10.2 Baxter International Description and Business Overview
7.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Baxter International Connected Injectable Drug Delivery Devices Products Offered
7.10.5 Baxter International Recent Development
7.11 Scandinavian Health
7.11.1 Scandinavian Health Corporation Information
7.11.2 Scandinavian Health Description and Business Overview
7.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Scandinavian Health Connected Injectable Drug Delivery Devices Products Offered
7.11.5 Scandinavian Health Recent Development
7.12 Ypsomed
7.12.1 Ypsomed Corporation Information
7.12.2 Ypsomed Description and Business Overview
7.12.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Ypsomed Products Offered
7.12.5 Ypsomed Recent Development
7.13 Terumo Medical
7.13.1 Terumo Medical Corporation Information
7.13.2 Terumo Medical Description and Business Overview
7.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Terumo Medical Products Offered
7.13.5 Terumo Medical Recent Development
7.14 Schott
7.14.1 Schott Corporation Information
7.14.2 Schott Description and Business Overview
7.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Schott Products Offered
7.14.5 Schott Recent Development
7.15 Owen Mumford
7.15.1 Owen Mumford Corporation Information
7.15.2 Owen Mumford Description and Business Overview
7.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Owen Mumford Products Offered
7.15.5 Owen Mumford Recent Development
7.16 Antares Pharma
7.16.1 Antares Pharma Corporation Information
7.16.2 Antares Pharma Description and Business Overview
7.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Antares Pharma Products Offered
7.16.5 Antares Pharma Recent Development
7.17 Zogenix
7.17.1 Zogenix Corporation Information
7.17.2 Zogenix Description and Business Overview
7.17.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Zogenix Products Offered
7.17.5 Zogenix Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Connected Injectable Drug Delivery Devices Industry Chain Analysis
8.2 Connected Injectable Drug Delivery Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Connected Injectable Drug Delivery Devices Distributors
8.3 Connected Injectable Drug Delivery Devices Production Mode & Process
8.4 Connected Injectable Drug Delivery Devices Sales and Marketing
8.4.1 Connected Injectable Drug Delivery Devices Sales Channels
8.4.2 Connected Injectable Drug Delivery Devices Distributors
8.5 Connected Injectable Drug Delivery Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
